Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology MFM
Publication stageIn Press Accepted Manuscript
Funding: No funding was received for this research ClinicalTrials.gov Identifier: NCT02819570. https://clinicaltrials.gov/ct2/show/NCT02819570
Data Sharing: Raw data were generated at Galilee Medical Center. The data derived that support the findings of this study are available from the corresponding author [MFW] on request.
Paper presentation information: Oral presentation during the 43nd Annual Pregnancy Meeting™ SMFM on February 9, 2023, San-Francisco California.
Disclosure statement: The authors report no conflicts of interest.
Condensation: Combined with roxithromycin, cefuroxime as a prophylactic for preterm pre-labor rupture of membranes <37 showed longer pregnancy and less maternal and neonatal morbidity than ampicillin.